123 related articles for article (PubMed ID: 38098250)
1. Comparative analysis of two arecoline-induced oral submucous fibrosis models.
Tang S; Jiang L; Zhou Y; Zhou T; Peng Y; Zhou S; Yue Y; Xia X; Li J; Chen Q; Jiang Y; Feng X
Oral Dis; 2023 Dec; ():. PubMed ID: 38098250
[TBL] [Abstract][Full Text] [Related]
2. Development of a mouse model of arecoline-induced oral mucosal fibrosis.
Wen QT; Wang T; Yu DH; Wang ZR; Sun Y; Liang CW
Asian Pac J Trop Med; 2017 Dec; 10(12):1177-1184. PubMed ID: 29268975
[TBL] [Abstract][Full Text] [Related]
3. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
4. Role of autophagy and apoptosis in atrophic epithelium in oral submucous fibrosis.
Zhu B; Jiang Q; Que G; Dai Z; Wu Y
J Oral Sci; 2020 Mar; 62(2):184-188. PubMed ID: 32132327
[TBL] [Abstract][Full Text] [Related]
5. Effects of arecoline, safrole, and nicotine on collagen phagocytosis by human buccal mucosal fibroblasts as a possible mechanism for oral submucous fibrosis in Taiwan.
Shieh DH; Chiang LC; Lee CH; Yang YH; Shieh TY
J Oral Pathol Med; 2004 Oct; 33(9):581-7. PubMed ID: 15357680
[TBL] [Abstract][Full Text] [Related]
6. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis.
Shieh DH; Chiang LC; Shieh TY
Oral Oncol; 2003 Oct; 39(7):728-35. PubMed ID: 12907213
[TBL] [Abstract][Full Text] [Related]
7. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
Lee YH; Yang LC; Hu FW; Peng CY; Yu CH; Yu CC
J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
[TBL] [Abstract][Full Text] [Related]
8. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
9. Role of autophagy induced by arecoline in angiogenesis of oral submucous fibrosis.
Dai Z; Zhu B; Yu H; Jian X; Peng J; Fang C; Wu Y
Arch Oral Biol; 2019 Jun; 102():7-15. PubMed ID: 30951892
[TBL] [Abstract][Full Text] [Related]
10. Jiawei Danxuan Koukang Alleviates Arecoline Induced Oral Mucosal Lesions: Network Pharmacology and the Combined Ultra-High Performance Liquid Chromatography (UPLC) and Mass Spectrometry (MS).
Zhou L; Tan J; Dai Y; Zhu K; Xiao Y; Wu D; Wang Z; Tan Y; Qin Y
Drug Des Devel Ther; 2023; 17():3085-3101. PubMed ID: 37854130
[TBL] [Abstract][Full Text] [Related]
11. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
Chang YC; Tsai CH; Lai YL; Yu CC; Chi WY; Li JJ; Chang WW
J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
[TBL] [Abstract][Full Text] [Related]
12. [Rat model with oral submucous fibrosis induced by arecoline and mechanical stimulation].
Yang B; Fu MF; Tang ZG
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Jun; 37(3):260-264. PubMed ID: 31218858
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine modification contributes to arecoline-mediated oral submucosal fibrosis.
Li X; Gao Y; Chen W; Gu Y; Song J; Zhang J; Ai Y
J Oral Pathol Med; 2022 May; 51(5):474-482. PubMed ID: 35377493
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study.
Singh V; Mohammad S; Pant AP; Saimbi CS; Srivastava R
J Maxillofac Oral Surg; 2015 Jun; 14(2):278-90. PubMed ID: 26028848
[TBL] [Abstract][Full Text] [Related]
15. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
16. Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation.
Yang HW; Yu CC; Hsieh PL; Liao YW; Chu PM; Yu CH; Fang CY
J Formos Med Assoc; 2021 Apr; 120(4):1108-1113. PubMed ID: 33191095
[TBL] [Abstract][Full Text] [Related]
17. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-13 contributes to the occurrence of oral submucosal fibrosis.
Wang L; Tang Z; Huang J
J Cell Mol Med; 2023 Jul; 27(13):1797-1805. PubMed ID: 37337411
[TBL] [Abstract][Full Text] [Related]
19. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
